Latest News and Press Releases

Dagens finale i Drughunter Dysten i Lundbecks hovedkvarter i Valby afslutter ni ugers intens jagt på fremtidens forskere. Siden februar har omkring 1000 elever fra gymnasier over hele landet prøvet...

Today's final round of the Drug Hunter Competition, taking place at Lundbeck's headquarters in Valby, culminates nine weeks of intensive hunt for the researchers of the future. Since February,...

Today's final round of the Drug Hunter Competition, taking place at Lundbeck's headquarters in Valby, culminates nine weeks of intensive hunt for the researchers of the future. Since February,...

Dagens finale i Drughunter Dysten i Lundbecks hovedkvarter i Valby afslutter ni ugers intens jagt på fremtidens forskere. Siden februar har omkring 1000 elever fra gymnasier over hele landet prøvet...

Bestyrelsen for H. Lundbeck A/S har, i overensstemmelse med bemyndigelsen i vedtægternes pkt. 4.4, besluttet at udstede tegningsoptioner ("warrants") for indtil i alt nominelt DKK 8.750.000 svarende...

H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of H. Lundbeck A/S has resolved, pursuant to the authorisation in article 4.4 of the company's articles of association, to...

På generalforsamlingen blev bestyrelsens beretning taget til efterretning og årsrapporten blev godkendt. Generalforsamlingen godkendte bestyrelsens vederlag for 2012. Generalforsamlingen...

At the general meeting the report by the Board of Directors was adopted and the Annual Report was approved. The general meeting approved the remuneration for the Board of Directors for...

I januar 2011 blev H. Lundbeck A/S (Lundbeck) opmærksom på, at en række amerikanske fængsler var begyndt at anvende pentobarbital - medicin udviklet til behandling af svære epileptiske anfald og...

In January 2011, H. Lundbeck A/S (Lundbeck) became aware that a number of US prisons had started using pentobarbital – medicine developed for the treatment of severe epileptic seizures and was...